Background: Veno-arterial extracorporeal life support (VA-ECLS) is widely used to treat
refractory cardiogenic shock. However, increased left ventricular (LV) afterload in VA-ECLS …

Purpose Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) can be used to
restore organ perfusion in patients with cardiogenic shock until native heart recovery occurs …

In 2009, the “Guidelines for diagnosis and treatment of myocarditis (JCS 2009)” were issued
by the Japanese Circulation Society (JCS). 1 Although this guideline has been widely used …

Background Prognoses and long‐term cardiac function of patients with fulminant myocarditis
have not been fully elucidated. Therefore, we clarified the prognoses and long‐term cardiac …

Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe
hemodynamic compromise secondary to acute myocardial inflammation, often presenting as …

Background Outcomes of patients requiring venoarterial extracorporeal membrane
oxygenation (VA-ECMO) vary greatly by etiology, but large studies that incorporate the …

目的: 回顾性分析静脉-动脉体外膜肺氧合(VA-ECMO) 对急性暴发性心肌炎(AFM)
合并心源性休克(CS) 患者的临床治疗效果. 方法: 回顾性分析2016 年6 月-2019 年12 …

OBJECTIVES Fulminant myocarditis with cardiogenic shock requires extracorporeal life
support (ECLS) and has poor outcomes. To improve outcomes, we have converted patients …

Venoarterial extracorporeal membrane oxygenation (VA ECMO) is a form of temporary
mechanical circulatory support and simultaneous extracorporeal gas exchange for acute …

Venoarterial extracorporeal membrane oxygenation may be used for circulatory support in
cardiogenic shock as a bridge to recovery, a bridge to a ventricular assist device (VAD), or a …